Clinical Outcomes of People Who Acquired HIV in Early Life

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

177 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-08-27

Study Completion Date

2023-03-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

\- Long-term survival with the human immunodeficiency virus (HIV) is not well understood. Adults who were infected with HIV as children have lived with the virus for many years. However, the effect of HIV on this group of people has not been studied in depth. Researchers are interested in studying how HIV infection and the medicines used to treat it affect people who were infected early in life. They want to find out if there are any problems with how HIV-infected children grow and develop as adults, especially if they have developed heart problems. As part of this study, people with HIV will be compared with healthy volunteers.

Objectives:

\- To study the effect of HIV infection and treatment on people who acquired HIV infection in early life.

Eligibility:

* Individuals at least 18 years of age who acquired HIV infection in early life.
* Healthy volunteers at least 18 years of age without HIV will serve as controls

Design:

* Participants will be screened with a physical exam and medical history. They will have regular study visits about once a year for up to 10 years to collect health information.
* Blood and urine samples will be collected to look at kidney and liver function.
* X-ray scans will be used to look at bone density and the amount of fat and muscle in the body.
* Treatment will not be provided as part of this study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences

NCT00675766

HIV Infections

COMPLETED

Analysis of HIV-1 Replication During Antiretroviral Therapy

NCT00767312

HIV

ENROLLING_BY_INVITATION

A Study of the Long-Term Outcomes of HIV-Positive Patients

NCT00000932

HIV Infections

COMPLETED

Treatment of Acute HIV Infection to Preserve Immune Function

NCT00055094

HIV Infections

COMPLETED

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

NCT03337906

HIV Infections

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

* Antiretroviral therapy (ART) has altered the natural history of HIV disease in children.
* Long-term survivors of pediatric HIV infection offer a tremendous opportunity to understand the effects of HIV and ART health outcomes.
* A thorough understanding of the impact of HIV and ART on these long-term processes is extremely relevant as ART programs for HIV-infected children expand globally.

Objective:

\- To explore the clinical outcomes and the impact of HIV infection and ART on a cohort with HIV infection acquired in early life

Eligibility:

* Individuals at least 18 years of age who acquired HIV infection in early life
* Healthy volunteers without HIV (greater than or equal to 18 years of age) will serve as controls

Design:

\- Annual evaluations of health status, immune function and other health parameters related to HIV infection will be conducted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Controls

Individuals with no known history of HIV

No interventions assigned to this group

Healthy Controls - Questionnaire Group

Individuals with no known history of HIV

No interventions assigned to this group

HIV

Individuals who acquired HIV in early life

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* HIV positive participants

* Known HIV infection, confirmed by laboratory testing and documented or believed to have been acquired during the first decade of life
* Age greater than or equal to 18 years
* HIV negative controls

* HIV negative, documented by a negative ELISA
* Age greater than or equal to 18 years
* Free of any major underlying medical disorder
* Not currently pregnant

For Reproductive Health Sub-Study:

* HIV positive participants

* Known HIV infection, confirmed by laboratory testing and documented or believed to have been acquired during the first decade of life
* Age greater than or equal to 18 years
* Capable of providing independent informed consent
* HIV negative controls

* HIV negative, verified by a negative ELISA
* Age greater than or equal to 18 years

For Healthy Volunteer, Questionnaire Group only

* Age \>=18 years
* No known history of HIV

Exclusion Criteria

Clinically significant condition or systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction) which in the judgment of the Principal Investigator would compromise the patient s ability to tolerate this study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No